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Article: Prevalence and risk factors of irritable bowel syndrome in healthy screenee undergoing colonoscopy and 
laboratory tests
(J Neurogastroenterol Motil 2010;16:47-51)
Irritable bowel syndrome (IBS) is a functional gastro-
intestinal disorder characterized by abdominal pain, discomfort 
and alteration of bowel habits, in the absence of organic disease.
1 
The prevalence of IBS is high worldwide, although it varies ac-
cording to the country and diagnostic criteria which has been 
used. 
Most large scale studies of the prevalence of IBS usually use 
the Manning or Rome II criteria, since the Rome III criteria was 
recently developed. In western studies, the prevalence of IBS is 
mostly about 10-20% in adolescents and adults,
2 although it is re-
ported up to approximately 25% in some studies.
3,4 In many west-
ern studies, IBS is predominant in females
5,6 with higher preva-
lence than eastern country.
7,8 There are many Asian studies about 
the prevalence of IBS. In one study from Korea, Han et al. con-
ducted a population based study that used telephone interviews 
using the Rome II criteria to diagnose IBS. In this Korean study, 
the prevalence of IBS was 6.6% and there was no significant dif-
ference between males and females, and subjects in their 20s had 
the highest IBS prevalence.
9 In another study from Hong Kong, 
Kwan et al. reported the prevalence of IBS as 6.6% using the 
Rome II criteria, while there was also no significant difference be-
tween males and females likewise.
10 In china, Xiong et al. re-
ported the adjusted prevalence of IBS in South China as 11.5% 
with the Manning criteria and 5.7% with the Rome II criteria; 
and they found no difference between males and females.
11 When 
compared with the western studies, the prevalence in Asian coun-
tries were relatively low, and female predominance was mostly not 
evident.   
The paper by Nam et al. in the issue of prevalence of IBS in 
Korea raises several important points. First, they used the re-
cently published Rome III criteria to diagnose IBS. Few studies 
have used these criteria to diagnose IBS. This paper can help us 
to know and compare the prevalence of IBS by Rome III. In this 
study, the prevalence of IBS was found to be 8.2% before and 
9.1% after organic disease was excluded via colonoscopy. By the 
study of Han et al. in 2006, the prevalence was 6.6%,
9 and 9.6% 
by Lee et al. in 2009.
12 Both studies used the Rome II criteria. 
The difference of approximately 3% between studies in 2006 and 
2009 may be explained by the increase in the prevalence of IBS. 
Recently, Wang et al. reported the accordance between Rome II Oh Young Lee
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and III to be good.
13 In addition, Dorn et al. found that the ac-
cordance between the two criteria was acceptable (kappa 0.79), 
and that the prevalence and proportions of  the subgroups were 
similar between two criteria.
14 However, Sperber et al. reported 
the prevalence of IBS as 2.9% for Rome II and 11.4% for Rome 
III, concluding Rome II as a much more strict criteria.
15 
Recently, Miwa reported the prevalence of IBS as 9.8% by Rome 
II and 13.1% by Rome III, and suggested that the Rome III cri-
teria is more sensitive than the Rome II criteria.
16 Second, this 
study excluded the organic bowel diseases through colonoscopy 
and laboratory exams, which was more accurate compared with 
many studies using only questionnaires through telephone or in-
ternet survey. By excluding the organic diseases with various 
tests, this study could estimate the prevalence of IBS more 
precisely. 
In this study, female gender, younger age, psychological 
stress, and current smoking were risk factors for IBS. In western 
studies using Rome II, from Spain, Australia and Canada, the fe-
male: male ratios were about 2:1.
17-20 In Nam’s study, the female 
was predominant in IBS patients, too. However, most Asian 
studies using Rome II criteria have not shown a significant differ-
ence in prevalence of IBS between male and female.
9,12,21,22 
Recently, one Japanese using Rome III reported the prevalence 
of IBS to be 15.5% in females and 10.7% among males. The 
Rome III criteria may uncover more female IBS patients than the 
Rome II, or the epidemiology of IBS in Asia may have become 
more similar to that in western countries. IBS is found frequently 
in all age groups.
23 However, the prevalence of IBS is higher in 
the younger age group than the older age group in many studies. 
Miwa reported the prevalence of diarrhea predominant IBS to be 
highest among males in their 20s, and constipation predominant 
IBS was most frequent among females in their 20s.
16 In the study 
of Han et al., the prevalence was also higher among those in their 
20s.
9 In Nam’s study, the younger age had a positive association 
with IBS, which is similar to the several western studies that sug-
gested the association between IBS and the younger age.
24-26 The 
psychological distress is a well known contributing factor for IBS 
and anxiety and depression are closely associated with IBS in 
many western studies. Nicholl et al.’s and Halzlett-Stevens et al.’s 
s t u d i e s  f o u n d  t h a t  a n x i e t y  i s  a n  i n d e p e n d e n t  r i s k  f a c t o r  f o r  
IBS.
27,28 Shen at al. reported the anxiety and depression to be sig-
nificantly  associated with IBS patients in China.
22 Similarly, psy-
chological stress was strongly a s s o c i a t e d  w i t h  I B S  i n  N a m ’ s  
study. The exact mechanism of psychological stress inducing the 
abdominal symptoms has not been discovered yet. Although re-
cently, many researchers have reported that there is a bidirec-
tional relationship between the brain (central nervous system) 
and the digestive tract. The most common opinion is that a com-
plex reflex circuit between the cerebral cortex and the digestive 
system exists, and brain-gut axis dysfunction can generate diges-
tive disorders.
29 
We still don’t fully understand about the role of smoking and 
alcohol on the development of IBS symptoms. In Nam’s study, 
current smoking was associated with IBS in multivariate analysis 
whereas alcohol consumption was not. There are few studies re-
garding the relationships between smoking, alcohol and IBS 
symptoms. In the study of Han et al., the odd ratio of smoking 
and alcohol was 0.64 (95% CI 0.37-1.12) and 1.38 (95% CI 
0.81-2.35) respectively.
9 Locke et al. reported alcohol and smok-
ing had no association with IBS.
30 However, Masand et al. sug-
gested a close relation between IBS and alcohol consumption, 
when they reported many more IBS patients in alcohol abuse or 
dependence than those who were not.
31 The disagreement in the 
relationships may be due to the fact that smoking and alcohol 
consumption have close correlations with stress, age, gender, so-
cioeconomic state, and national traditions, therefore it rather re-
flects a multiplicity of different factors which affect the physio-
logic state of the digestive system.
In conclusion, Nam’s study is the first large scale IBS study 
in Korea using the  Rome III criteria which excluded the organic 
diseases by colonoscopy and laboratory tests. However, this study 
has several limitations. First, the study population was partic-
ipants in the health screening program, so this study population 
cannot represent the entire Korean population. Second, this study 
did not analyze the prevalence and characteristics of each subtype 
of IBS. In spite of these limitations, this study has contributed 
greatly to the understanding of the epidemiology and risk factors 
of IBS in Korea with a recent updated diagnostic criteria.
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